Biowin members

neuroClues by P3Lab

Rue du Morimont 33
1341 CEROUX-MOUSTY
Belgium
[email protected] p3lab.com

neuroClues develops an eye-tracking solution for early detection of neurological diseases by analyzing eye movements to identify specific biomarkers

About

In a world where neurological disorders will affect 1 person in 3 and where the number of Parkinson’s patients will double in the next decade, reaching 13 million patients, our mission is to empower clinicians with biomarkers allowing them to identify neurological disorders (Parkinson’s Disease, Alzheimer’s Disease, and Multiple Sclerosis) years before visible symptoms.

Related news

News

Learn more
Image-4-1024x768

neuroClues secures CE certification for its eye-tracking technology set to enhance neurologic care

    Press release

07.01.2025

Connect with us

Contact